Cargando…
Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression
Surgery is the primary therapeutic strategy for most solid tumours; however, modern oncology has established that neoplasms are frequently systemic diseases. Being however a local treatment, the mechanisms through which surgery plays its systemic role remain unknown. We have investigated the influen...
Autores principales: | Napoletano, Chiara, Bellati, Filippo, Landi, Rachele, Pauselli, Simona, Marchetti, Claudia, Visconti, Valeria, Sale, Patrizio, Liberati, Marco, Rughetti, Aurelia, Frati, Luigi, Panici, Pierluigi Benedetti, Nuti, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822725/ https://www.ncbi.nlm.nih.gov/pubmed/19780872 http://dx.doi.org/10.1111/j.1582-4934.2009.00911.x |
Ejemplares similares
-
Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets
por: Napoletano, Chiara, et al.
Publicado: (2019) -
Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View
por: Bellati, Filippo, et al.
Publicado: (2011) -
Immune Effects of Trastuzumab
por: Nuti, Marianna, et al.
Publicado: (2011) -
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer
por: Napoletano, Chiara, et al.
Publicado: (2013) -
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial
por: ANTONILLI, MORENA, et al.
Publicado: (2016)